Drugs and MoA Flashcards
sodium valporate
inhibits voltage-gated sodium channels which stabilises the neurotransmitters in the brain to stop the seizure.
carbamezepine
decreases neuronal excitability or enhances inhibition by altering sodium, potassium or calcium conductance or affecting GABA, glutamate or other neurotransmitters that cause seizure activity.
Lamotrigine
inhibits voltage gated sodium channels which stabilises and inhibits presynaptic glutamate.
Levetiracetam
modulates the synaptic neurotransmission release via binding to the protein SV2A.
Topiramate
increases GABA by inhibiting glutamate activity.
Phenytoin
voltage gated sodium channel blocker
Gabapentinoids
inhibits calcium release
SSRIs(1st) such as Citalopram, fluoxetine, sertraline, paroxetine
selectively inhibit the re-uptake of serotonin (5HT) in the synapse at the serotonin transporters (SERT)
SNRIs such as venlafaxine, duloxetine
these drugs target SERT AND NET (norepinephrine transporters) and block the reuptake of serotonin and norepinephrine.
TCAs such as Amitriptyline, Clomipramine, Imipramine, Nortriptyline
Also target SERT and NET but also have inhibitory effects on sodium channels in the heart and histamine receptors causing them to be more sedating. The first two listed are more sedating than the second two listed.
MAOIs such as phenelzine sulphate, moclobemide, selegiline HCl
target the Monoamine oxidase enzyme that are located within the synapse and are responsible for the degradation of 5HT, DA and NE. By stopping their breakdown, levels of each remain higher.
Atypical: Bupropion
weak NE and DA reuptake inhibitor. Mirtazapine – a2 receptor antagonist that increases 5HT and NE transmission. Trazodone – inhibits SERT and blocks postsynaptic 5HT receptors.
lithium
still unknown
Dopamine precursors such as levodopa preparations like levodopa + carbidopa/benserazide
these directly add more dopamine into the brain. The co-admission stop levodopa from being broken down in the gut and allow it to cross the BBB to be used in the brain.
Dopamine agonists such as Ropinirole, Pramipexole, Rotigotine, apomorphine
stimulate the dopamine receptors to cause more dopamine to be released.
COMTIs such as Entacapone and Tolcapone
inhibits COMT enzymes which break down dopamine in the brain and levodopa in the periphery
All Benzodiazepines -
effect the Chlorine channel which is normally stimulated by GABA.
Benzodiazepines have a binding site between the gamma and alpha subunits. Once bound allosterically, benzodiazepines increase the frequency of the channel opening. Anion channels dampen fear and stress responses so reduces anxiety.
Adrenergic B-receptor blockers, Bisoprolol, propranolol
Reduce sympathetic manifestation of the heart by blocking those receptors in the heart which reduces the symptoms expressed from anxiety.
Serotonin pathways, Buspirone + antidepressants
Buspirone is a partial 5-HT agonist whilst other antidepressants are listed above.
1st generation antipsychotics, Chlorpromazine, Benperidol, Flupentixol –
high affinity to the D2 dopamine receptor. It’s only effective against positive symptoms e.g hallucinations.
2nd generation antipsychotics, Aripiprazole, Risperidone, Olanzapine
Low affinity to D2 receptor, they tend to inhibit the 5HT receptor more. They have less extrapyrimidal side effects and target positive and negative symptoms.
Hyoscine Hydrobromide
Anticholinergic, relaxes smooth muscles which can help with travel sickness and cramps.
Metoclopramide (anti-emetic)
acts directly on gastric smooth muscle which stimulates gastric emptying and also blocks the 5HT receptors.
Methoxsalen, Khelling, Photofrin (for Vitiligo, psoriasis, cutaneous t-cell lymphoma, graft-versus-host disease)
all contain the psoralen skeleton, these are used alongside UV therapy to make PUVA. Psoralen intercalates into DNA and once exposed to UV it forms adducts with pyrimidine bases. This adduct can be further excited by a proton to blind again with another thymine forming covalent interstrand crosslinks. All this ultimately stops cell multiplication.